Showing 3301-3310 of 5603 results for "".
- Liver Tumor Microproteins Could Be Key to Developing New Cancer Vaccineshttps://reachmd.com/news/liver-tumor-microproteins-could-be-key-to-developing-new-cancer-vaccines/2467351/In a new study published in Science Advances, scientists at Hospital del Mar Research Institute (IMIM) and their collaborators at the Center for Applied Medical Research (CIMA), the University of Navarra, and Pompeu Fabra University descri
- Food Insecurity and Nutrition Insecurity Challenge LA Countyhttps://reachmd.com/news/food-insecurity-and-nutrition-insecurity-challenge-la-county/2467314/While food insecurity has long been the focus of local and national policymakers and researchers, nutrition insecurity has largely been overlooked. A new study b
- Young People See AI as Valuable Healthcare Toolhttps://reachmd.com/news/young-people-see-ai-as-valuable-healthcare-tool/2467315/Children and young people are generally positive about artificial intelligence (AI) and think it should be used in modern healthcare, finds the first-of-its-kind survey led by UCL and Great Ormond Street Hospital (GOSH). The national study asked children
- Researchers Build First-Ever Molecular Atlas of Blood Vessel Pathways in Human Brainhttps://reachmd.com/news/researchers-build-first-ever-molecular-atlas-of-blood-vessel-pathways-in-human-brain/2467316/Construction of a molecular sc-atlas of the human brain vasculature and reactivation of fetal programs in pathological brain vascular ECs. Credit: Nature (2024). DOI: 10.1038/s4158
- England's NICE Recommends Lebrikizumab for Moderate-to-Severe ADhttps://reachmd.com/news/englands-nice-recommends-lebrikizumab-moderate-severe-ad/2467289/England’s National Institute for Health and Care Excellence (NICE) has recommended lebrikizumab for use in treating moderate-to-severe atopic dermatitis, Almirall S.A. announced in a press release. Lebrikizumab, sold by Almirall under the brand name Ebglyss, is indicated for the treatment
- Could a Dietary Fiber Supplement Offer Long-Awaited Treatment for Food Allergy Sufferers?https://reachmd.com/news/could-a-dietary-fiber-supplement-offer-long-awaited-treatment-for-food-allergy-sufferers/2467292/A study from the University of Michigan has identified a potential new treatment for food allergies in inulin, a naturally occurring plant fiber commonly used as a supplement, a prebiotic in soda, a replacement for sweeteners and for other products and purposes.
- US Health Officials Strengthen Endorsement of RSV Shots for Oldest Americanshttps://reachmd.com/news/us-health-officials-strengthen-endorsement-of-rsv-shots-for-oldest-americans/2467276/NEW YORK (AP) — U.S. health officials on Wednesday made a stronger endorsement for RSV vaccinations for people 75 and older, but offered a narrower rec
- Bowel Cancer Turns Genetic Switches On and Off to Outwit the Immune System, New Study Findshttps://reachmd.com/news/bowel-cancer-turns-genetic-switches-on-and-off-to-outwit-the-immune-system-new-study-finds/2467256/Frameshift switching of the MSH6 C8 coding homopolymer drives stochastic loss and restoration of MSH6 expression like a molecular ON/OFF switch. Credit: Nature Genetics (2024). DOI
- Popular Prescription Weight Loss Drugs Linked to Uncommon Blinding Conditionhttps://reachmd.com/news/popular-prescription-weight-loss-drugs-linked-to-uncommon-blinding-condition/2467260/A new Mass Eye and Ear-led study is the first to discover that people prescribed semaglutide, sold as Ozempic and Wegovy, have a higher risk of developing a form of blindness due to optic nerve disease known as non-arteritic anterior ischemic optic neuropathy (NAION). <
- Discovery of Cellular Mechanism to Maintain Brain's Energy Could Benefit Late-Life Brain Healthhttps://reachmd.com/news/discovery-of-cellular-mechanism-to-maintain-brains-energy-could-benefit-late-life-brain-health/2467251/Deletion of A2B receptors in hippocampal astrocytes. Credit: Nature (2024). DOI: 10.1038/s41586-024-07611-w A key mec